Page last updated: 2024-09-04

moxifloxacin and ro13-9904

moxifloxacin has been researched along with ro13-9904 in 38 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (ro13-9904)	Trials (ro13-9904)	Recent Studies (post-2010) (ro13-9904)
3,157	552	1,690	6,815	798	2,755

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (7.89)	18.2507
2000's	20 (52.63)	29.6817
2010's	12 (31.58)	24.3611
2020's	3 (7.89)	2.80

Authors

Authors	Studies
Frimodt-Møller, N; Knudsen, JD; Ostergaard, C; Sørensen, TK	1
Bianco, G; Capone, A; Cassone, M; Tarasi, A; Tarasi, D; Venditti, M	1
Eiffert, H; Mäder, M; Nau, R; Schmidt, H; Stuertz, K; Trostdorf, F	1
Ghaffar, F; Hardy, RD; Jafri, HS; McCoig, CC; McCracken, GH; Michelow, IC; Olsen, K; Patel, C; Rodriguez-Cerrato, V	1
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A	1
Appelbaum, PC; Bozdogan, B; Browne, FA; Clark, C; Dewasse, BE; Jacobs, MR	1
Casali, L; Curti, E; Grassi, C; Lazzaro, C; Schito, G; Tellarini, M	1
Brooke, CJ; Hampson, DJ; Riley, TV	1
Choi, JH; Choi, SM; Kim, SH; Lee, DG; Shin, WS; Song, MJ; Yoo, JH	1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L; Tocalli, L	1
Choudhri, S; Fogarty, CM; Hamed, K; Katz, E; Larsen, LS; Song, J	1
Böttcher, T; Brocke, VV; Djukic, M; Eiffert, H; Gerber, J; Nau, R; Wellmer, A	1
Bauer, TT; Petermann, W; Reimnitz, P; Schürmann, D; Welte, T	1
Appelbaum, PC; Bogdanovich, T; Clark, C; Ednie, L; Lin, G; Shapiro, S; Smith, K	1
Barth, J; Beckmann, H; Höffken, G; Rubinstein, E	1
Ruef, C	1
Bachelot, T; Biron, P; Chelghoum, M; Chvetzoff, G; Devaux, Y; Dussart, S; Fuhrmann, C; Geoffrois, L; Ghesquieres, H; Lancry, L; Rodrigues, I; Sebban, C	1
Denizbasi, A; Erdede, M; Guneysel, O; Onur, O	1
Evers, T; Holman, A; Lloyd, A	1
Arvis, P; Carlet, J; Choudhri, S; Garau, J; Kureishi, A; Le Berre, MA; Lode, H; Read, RC; Torres, A; Winter, J	1
Guggemos, W; Seilmaier, M	1
Hampel, B; Lippert, H; Muehlhofer, E; Reimnitz, P; Weiss, G	1
Bhattacharya, B; Habr, F; Manlolo, J; Robinson, W	1
Chen, MJ; Hampel, B; Ma, EL; Solomkin, J; Zhao, YP	1
Adebambo, B; Senthilvel, E; Shah, C	1
Jacobus, NV; McDermott, LA; Snydman, DR	1
Goldstein, RC; Husk, G; Jodlowski, T; Mildvan, D; Perlman, DC; Ruhe, JJ	1
Balla, J; Fehérvári, I; Kertész, A; Nemes, B; P Szabó, R; Szerafin, T; Zsom, L	1
Freeman, J; Vernon, J; Vickers, R; Wilcox, MH	1
Bettoli, V; Join-Lambert, O; Nassif, A	1
Bakker, M; Brandsema, PS; Bruin, JP; Den Boer, JW; Diederen, BM; Euser, SM; Honing, ML; Reijnen, L	1
Fukao, E; Honma, Y; Horiuchi, I; Nakahara, H; Oda, T; Uchigata, M	1
Davydov, A; Karpov, I; Salavei, M; Titov, L	1
Bang, KB; Kim, HJ; Kim, NH	1
He, R; Hu, Y; Huang, Y; Liu, C; Liu, H; Long, J; Wang, Q; Xie, H; Xing, L; Yan, Z; Zheng, W	1
Kozlova, A; Michael, A; Palazzolo, L	1
Chen, HC; Chen, KJ; Chen, YP; Chong, YJ; Kang, EY; Lai, CC; Liu, L; Sun, MH; Wu, WC	1
Allen, GP; Deao, KM; Hill, SA; Schipelliti, SM; Tran, T	1

Reviews

1 review(s) available for moxifloxacin and ro13-9904

Article	Year
Antibiotic Treatment of Hidradenitis Suppurativa. Dermatologic clinics, 2016, Volume: 34, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin	2016

Trials

10 trial(s) available for moxifloxacin and ro13-9904

Article	Year
Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Acute Disease; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Ceftriaxone; Costs and Cost Analysis; Female; Fluoroquinolones; Humans; Italy; Male; Middle Aged; Moxifloxacin; National Health Programs; Quinolines; Time Factors; Treatment Outcome	2002
Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy. The Journal of emergency medicine, 2004, Volume: 27, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ceftriaxone; Community-Acquired Infections; Constipation; Drug Therapy, Combination; Emergency Medical Services; Female; Fluoroquinolones; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Nausea; Pneumonia, Bacterial; Prospective Studies; Quinolines; Safety; Time Factors; Treatment Outcome	2004
Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Dec-15, Volume: 41, Issue:12 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Hospitalization; Humans; Injections, Intravenous; Male; Moxifloxacin; Parenteral Nutrition; Pneumonia, Bacterial; Prospective Studies; Quinolines; Remission Induction; Time Factors	2005
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia. Infection, 2007, Volume: 35, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Ceftriaxone; Cefuroxime; Cross Infection; Drug Therapy, Combination; Endpoint Determination; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Treatment Outcome	2007
Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2008, Volume: 16, Issue:9 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Aza Compounds; Ceftriaxone; Female; Fever; Fluoroquinolones; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Neoplasms; Neutropenia; Patient Discharge; Quinolines; Risk Factors; Time Factors	2008
A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial. Current medical research and opinion, 2008, Volume: 24, Issue:5 Topics: Administration, Oral; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Cost of Illness; Cost-Benefit Analysis; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Hospitalization; Humans; Infusions, Intravenous; Length of Stay; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Quinolines; Severity of Illness Index; Treatment Outcome	2008
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Quinolines; Severity of Illness Index; Treatment Outcome	2008
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study). Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2 Topics: Abdominal Abscess; Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Appendicitis; Aza Compounds; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Peritonitis; Prospective Studies; Quinolines	2009
Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections. International journal of antimicrobial agents, 2009, Volume: 34, Issue:5 Topics: Adult; Anti-Bacterial Agents; Asia; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Peritonitis; Quinolines; Treatment Outcome	2009
Prospective comparison of prophylactic antibiotic use between intravenous moxifloxacin and ceftriaxone for high-risk patients with post-ERCP cholangitis. Hepatobiliary & pancreatic diseases international : HBPD INT, 2017, Oct-15, Volume: 16, Issue:5 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Ceftriaxone; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies	2017

Other Studies

27 other study(ies) available for moxifloxacin and ro13-9904

Article	Year
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:7 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Drug Evaluation; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Protein Binding; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Time Factors; Vancomycin	1998
Comparative in-vitro activity of moxifloxacin, penicillin, ceftriaxone and ciprofloxacin against pneumococci isolated from meningitis. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Ciprofloxacin; Fluoroquinolones; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Moxifloxacin; Penicillins; Pneumococcal Infections; Quinolines; Streptococcus pneumoniae	1999
Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone. Scandinavian journal of infectious diseases, 1999, Volume: 31, Issue:4 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Disease Models, Animal; Fluoroquinolones; Immunoenzyme Techniques; Lipopolysaccharides; Meningitis, Pneumococcal; Moxifloxacin; Naphthyridines; Polysaccharides, Bacterial; Quinolines; Rabbits; Reference Values; Rifabutin; Teichoic Acids; Virginiamycin	1999
Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:11 Topics: Animals; Anti-Infective Agents; Area Under Curve; Aza Compounds; Ceftriaxone; Cephalosporins; Escherichia coli; Fluoroquinolones; Male; Meningitis, Escherichia coli; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Thienamycins	2001
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. International journal of antimicrobial agents, 2002, Volume: 19, Issue:2 Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin	2002
Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin. International journal of antimicrobial agents, 2002, Volume: 20, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Culture Media; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Quinolines; Selection, Genetic; Streptococcus pneumoniae	2002
In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Chloramphenicol; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Meropenem; Metronidazole; Moxifloxacin; Quinolines; Spirochaetales; Swine; Tetracycline; Thienamycins	2003
Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:12 Topics: Adjuvants, Immunologic; Anti-Infective Agents; Aza Compounds; Blotting, Western; Ceftriaxone; Cell Survival; Cephalosporins; Cytokines; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Flow Cytometry; Fluoroquinolones; Humans; I-kappa B Proteins; In Vitro Techniques; Interleukin-6; Lipopolysaccharide Receptors; Monocytes; Moxifloxacin; Ofloxacin; Quinolines; Streptococcus pneumoniae; Tumor Necrosis Factor-alpha	2003
Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Clarithromycin; Dose-Response Relationship, Drug; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Moxifloxacin; Quinolines	2004
Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis. Neurocritical care, 2005, Volume: 2, Issue:3 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Disease Models, Animal; Drug Administration Schedule; Fluoroquinolones; Injections, Subcutaneous; Male; Meningitis, Pneumococcal; Mice; Mice, Inbred C57BL; Moxifloxacin; Quinolines; Treatment Outcome	2005
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Azithromycin; beta-Lactamases; Cefpodoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus influenzae; Humans; In Vitro Techniques; Ketolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Quinolines; Selection, Genetic	2006
Nosocomial pneumonia - are economical considerations important? Infection, 2007, Volume: 35, Issue:6 Topics: Administration, Oral; Aza Compounds; Ceftriaxone; Cefuroxime; Cross Infection; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia; Quinolines	2007
Trimethoprim/sulfamethoxazole resistance in urinary tract infections. The Journal of emergency medicine, 2009, Volume: 36, Issue:4 Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Aza Compounds; Ceftriaxone; Drug Resistance, Microbial; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2009
[Severe febrile illness with renal impairment after travel to Southeast Asia]. Der Internist, 2008, Volume: 49, Issue:11 Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Asia, Southeastern; Aza Compounds; Ceftriaxone; Fever of Unknown Origin; Fluoroquinolones; Humans; Leptospirosis; Male; Moxifloxacin; Quinolines; Travel; Treatment Outcome	2008
Moxifloxacin associated vanishing bile duct syndrome. Journal of clinical gastroenterology, 2010, Volume: 44, Issue:1 Topics: Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Azithromycin; Bile Duct Diseases; Ceftriaxone; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Syndrome	2010
Red eye, blurry vision, and cough. The Journal of family practice, 2010, Volume: 59, Issue:4 Topics: Anti-Infective Agents; Aortic Valve; Aortic Valve Insufficiency; Aza Compounds; Blindness; Ceftriaxone; Cough; Echocardiography, Transesophageal; Endophthalmitis; Fever; Fluoroquinolones; Hearing Loss, Sensorineural; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Moxifloxacin; Pneumococcal Infections; Quinolines; Streptococcus pneumoniae; Vancomycin; Vision Disorders	2010
In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Ceftaroline; Ceftriaxone; Cephalosporins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline	2011
Fluoroquinolone- and ceftriaxone-based therapy of community-acquired pneumonia in hospitalized patients: the risk of subsequent isolation of multidrug-resistant organisms. American journal of infection control, 2014, Volume: 42, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bacteria; Ceftriaxone; Cohort Studies; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Young Adult	2014
[Infective endocarditis caused by Chlamydia pneumoniae after liver transplantation. Case report]. Orvosi hetilap, 2015, May-31, Volume: 156, Issue:22 Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve; Aphasia; Brain; Calcineurin; Ceftriaxone; Chlamydia; Coronary Artery Bypass; Drug Administration Schedule; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Fluoroquinolones; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Liver Transplantation; Magnetic Resonance Imaging; Middle Aged; Moxifloxacin; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome	2015
Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Benzimidazoles; Ceftriaxone; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Fidaxomicin; Fluoroquinolones; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Phenotype; Pyridines; Ribotyping; Vancomycin	2016
Legionnaires' disease after a campervan holiday: a case report. Journal of travel medicine, 2016, Volume: 23, Issue:1 Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Fluoroquinolones; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Motor Vehicles; Moxifloxacin; Travel	2016
A case of meningococcal meningitis that was difficult to treat owing to concurrent ventriculitis. Rinsho shinkeigaku = Clinical neurology, 2016, 05-31, Volume: 56, Issue:5 Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Ceftriaxone; Cerebral Ventriculitis; Drug Substitution; Fluoroquinolones; Humans; Magnetic Resonance Imaging; Male; Meningitis, Meningococcal; Middle Aged; Moxifloxacin; Recurrence; Treatment Outcome	2016
First report of ceftriaxone-resistant Streptococcus pneumoniae meningitis in Belarus. Journal of global antimicrobial resistance, 2017, Volume: 11 Topics: Ceftriaxone; Dexamethasone; Drug Resistance, Bacterial; Humans; Intensive Care Units; Male; Meningitis, Pneumococcal; Meropenem; Middle Aged; Molecular Typing; Moxifloxacin; Republic of Belarus; Streptococcus pneumoniae; Treatment Outcome	2017
Vibrio vulnificus meningoencephalitis in a patient with thalassemia and a splenectomy. Journal of neurovirology, 2019, Volume: 25, Issue:1 Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Doxycycline; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Meningoencephalitis; Moxifloxacin; Seafood; Seawater; Sepsis; Splenectomy; Thalassemia; Treatment Outcome; Vibrio vulnificus	2019
Neisseria sicca: A Rare Cause of Bacterial Conjunctivitis. The American journal of case reports, 2020, Jun-15, Volume: 21 Topics: Anti-Bacterial Agents; Ceftriaxone; Conjunctivitis, Bacterial; Humans; Male; Moxifloxacin; Neisseria sicca; Neisseriaceae Infections	2020
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes. Scientific reports, 2021, 03-18, Volume: 11, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; Cefuroxime; Corneal Ulcer; Endophthalmitis; Eye Enucleation; Eye Injuries; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillins; Pneumococcal Infections; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Taiwan; Tertiary Care Centers; Trabeculectomy; Treatment Outcome; Vancomycin; Vitrectomy	2021
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae. International journal of antimicrobial agents, 2021, Volume: 58, Issue:4 Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Multiple, Bacterial; Ertapenem; Gentamicins; Gonorrhea; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Neisseria gonorrhoeae	2021